To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Effect of Dexmedetomidine–Ropivacaine Block on Flap Perfusion & Satisfaction After Hand Flap Surgery

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
July 2025

Effect of Dexmedetomidine–Ropivacaine Block on Flap Perfusion & Satisfaction After Hand Flap Surgery

Vol: 307| Issue: 7| Number:22| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Effect of dexmedetomidine combined with ropivacaine block on flap blood flow and patient satisfaction after flap transfer for hand trauma: a randomized controlled trial.

J Hand Surg Eur Vol . 2025 Apr;50(4):523-530.

Contributing Authors:
J Zhao X Kong Z Zheng P Lv Y Ge J Huang

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Sixty-six patients undergoing anterolateral thigh free flap transfer for hand trauma were randomized to receive either intermittent 1.0 mg/mL dexmedetomidine + 0.125% ropivacaine (n=29) or 0.2% ropivacaine alone (n=31) via continuous infraclavicular brachial plexus block. The primary outcome was flap blood flow parameters, including peak systolic and diastolic velocities, resistance index, and art...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue